75.00 -0.48 (-0.64%)
After hours: 6:14PM EST
|Bid||74.40 x 1300|
|Ask||75.38 x 1000|
|Day's Range||75.37 - 77.69|
|52 Week Range||59.07 - 86.31|
|Beta (3Y Monthly)||0.41|
|PE Ratio (TTM)||14.95|
|Earnings Date||Dec 20, 2018|
|Forward Dividend & Yield||1.76 (2.24%)|
|1y Target Est||78.23|
- Q3 share repurchases increase 57.7% year over year to a record $203.8 billion - This is the third consecutive quarterly record, up 6.9% from Q2 2018 - Q1 to Q3 year-to-date expenditures are only 1% shy ...
Several planned developments, early benefits from new pharmacy contracts as well as increased volumes are consistently driving growth within Walgreens Boots' (WBA) Retail Pharmacy USA division.
Short interest is low for WBA with fewer than 5% of shares on loan. The net inflows of $13.54 billion over the last one-month into ETFs that hold WBA are not among the highest of the last year and have been slowing.
Next week is gearing up to be a busy week with events that have potential to move the market as the FOMC meets, government shutdown looms and Nike reports earnings.
Paul J. Isaac‘s Arbiter Partners Capital Management LLC is an employee-owned, New York-based hedge fund, founded back in January 2001. Besides managing client focused portfolios, the firm provides its services to pooled investment vehicles and insurance companies. In the current climate of uncertainty, the fund’s CEO and founder Paul J. Isaac looks for value while […]
Short interest is low for WBA with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
Walgreens Boots Alliance Inc. shares fell 4% Friday, after Goldman Sachs downgraded the stock to sell from neutral, citing concerns about a deteriorating performance at its core retail pharmacy business as reimbursement rates fall and front-end sales decline.
U.S. stocks slumped on Friday as weak data from China and Europe stoked fears of a global economic slowdown, while Johnson & Johnson slid after Reuters reported the company knew for decades that asbestos lurked in its Baby Powder. The report, which J&J has disputed, sent the company's shares tumbling 8.31 percent in heavy volume. The stock was easily the biggest drag on the S&P 500 and the Dow Industrials.
"We downgrade WBA to Sell as challenges in its retail pharmacy business have intensified, forcing the company to search for other avenues of growth," Goldman Sachs analysts wrote in a note. The challenges Walgreens faces are part of a broader negative picture for pharmacies, according to Goldman. On the revenue side of the equation, price increases in the industry have been bleak.
The consumer goods and medical company slumped about 7%, wiping off $24 billion from its market capitalization, after Reuters reported that it knew about the presence of asbestos as early as 1971 and hired ghostwriters to redraft studies of its baby powder.
A new earnings season is also on the horizon, and a fresh batch of companies have the opportunity to ease Wall Street's nerves if they can post strong results. Here's a look at a few of the earnings announcements due during the week of December 17.
The problem began in 1986 when doctors and health organizations began advocating for the use of opioids to treat chronic pain, according to the Mayo Clinic. From rural West Virginia to Chicago’s inner city, communities have been inundated with prescription pain killers and their illicit counterparts like heroin. As a result of our health care system’s overreliance on opioids, there are an estimated 2 million Americans who are dependent on opioids.
Goldman analyst Robert Jones said he doesn't think Walgreens' numerous partnerships with other companies will help offset declines in its core retail pharmacy business. He downgraded Walgreens to "sell" from "hold" Friday.
Goldman analyst Robert Jones said he doesn't think Walgreens' numerous partnerships with other companies will help offset declines in its core retail pharmacy business. He downgraded Walgreens to "sell" ...
U.S. stocks fell 0.8 percent on Friday, as weak economic data from China and Europe exacerbated global growth fears and added to nerves about the U.S.-China trade talks. Weak monthly retail sales growth ...
Dow Jones stocks Walgreens and Cisco Systems headlined Friday's early losses, as stock futures fell hard in premarket trade.
The fifth seasonal Flu Index kicks off with Brownsville, Texas topping the list for flu activity; it serves as an important reminder to take preventive measures to stay healthy thi
The news from Adial Pharmaceuticals (NASDAQ:ADIL) has to do with the company’s AD04 asset. This is a drug from the company that is used to treat individuals suffering from alcohol use disorder. The good news for ADIL stock is that the company is considering expanding the use of AD04.
Amazon (AMZN) stock has fallen over 16% in the last three months as part of the larger market pullback driven by the likes of Apple (AAPL) and other giants. The company's days of 40% top-line growth might also be over. But let's dive into Amazon's overall business picture and outlook to see if investors should buy AMZN stock heading into 2019.
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Walgreens Boots, Duke Energy, Stryker, Kinder Morgan and PepsiCo
Walgreens Boots Alliance (WBA) closed at $82.44 in the latest trading session, marking a +0.77% move from the prior day.
Walgreens Boots Alliance, Inc. (WBA) today announced it will be transferring the securities exchange listing for its 2.125% Senior Notes due 2026, 2.875% Senior Notes due 2020 and 3.600% Senior Notes due 2025 from the New York Stock Exchange to the Nasdaq Bond Exchange effective December 21, 2018 after market close. The debt securities are expected to begin trading on the Nasdaq Bond Exchange on December 24, 2018.
Missouri becomes the 46th state where Walgreens offers its safe medication disposal program